{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:13Z","timestamp":1794047413056,"version":"4.8.0"},"reference-count":49,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"11","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Patients with newly diagnosed acute promyelocytic leukemia (APL) are often obese or overweight, accompanied by metabolic disorders, such as dyslipidemia. However, the link between dyslipidemia and leukemia is obscure. Here, we conducted a retrospective study containing 1,412 cases (319 newly diagnosed APL patients, 393 newly diagnosed non-APL acute myeloid leukemia patients, and 700 non-tumor controls) and found that APL patients had higher triglyceride levels than non- APL and control groups. Using clinical data, we revealed that hypertriglyceridemia served as a risk factor for early death in APL patients, and there was a positive correlation between triglyceride levels and leukocyte counts. RNA sequencing analysis of APL patients having high or normal triglyceride levels highlighted the contribution of peroxisome proliferatoractivated receptor-\u03b1 (PPAR\u03b1), a crucial regulator of cell metabolism and a transcription factor involved in cancer development. The genome-wide chromatin occupancy of PPAR\u03b1 revealed that PPAR\u03b1 co-existed with PML\/RAR\u03b1 within the super-enhancer regions to promote cell proliferation. PPAR\u03b1 knockdown affected the expression of target genes responsible for APL proliferation, including FLT3, and functionally inhibited the proliferation of APL cells. Moreover, in vivo results in mice having high fat diet-induced high triglyceride levels supported the connection between high triglyceride levels and the leukemic burden, as well as the involvement of PPAR\u03b1-mediated-FLT3 activation in the proliferation of APL cells. Our findings shed light on the association between APL proliferation and high triglyceride levels and provide a genetic link to PPAR\u03b1-mediated hyperlipidemia in APL.<\/jats:p>","DOI":"10.3324\/haematol.2021.280147","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T05:29:41Z","timestamp":1652333381000},"page":"2589-2600","source":"Crossref","is-referenced-by-count":18,"title":["Interplay between hypertriglyceridemia and acute promyelocytic leukemia mediated by the cooperation of peroxisome proliferator-activated receptor-\u03b1 with the PML\/RAR \u03b1 fusion protein on super-enhancers"],"prefix":"10.3324","volume":"107","author":[{"given":"Shishuang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kankan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"key":"41061","doi-asserted-by":"crossref","unstructured":"Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet. 2014; 384(9945):755-765.","DOI":"10.1016\/S0140-6736(14)60892-8"},{"key":"41062","doi-asserted-by":"crossref","unstructured":"Castillo JJ, Mulkey F, Geyer S. Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials. Am J Hematol. 2016; 91(2):199-204.","DOI":"10.1002\/ajh.24230"},{"key":"41063","doi-asserted-by":"crossref","unstructured":"Estey E, Thall P, Kantarjian H, Pierce S, Kornblau S, Keating M. Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia. Leukemia. 1997; 11(10):1661-1664.","DOI":"10.1038\/sj.leu.2400783"},{"key":"41064","doi-asserted-by":"crossref","unstructured":"Mazzarella L, Botteri E, Matthews A. Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with flt3 mutations and polyunsaturated fatty acid metabolism. Haematologica. 2020; 105(6):1559-1566.","DOI":"10.3324\/haematol.2019.223925"},{"key":"41065","doi-asserted-by":"crossref","unstructured":"Currie E, Schulze A, Zechner R, Walther Tobias C, Farese Robert V. Cellular fatty acid metabolism and cancer. Cell Metab. 2013; 18(2):153-161.","DOI":"10.1016\/j.cmet.2013.05.017"},{"key":"41066","doi-asserted-by":"crossref","unstructured":"Nomura DK, Long JZ, Niessen S, Hoover HS, Ng S-W, Cravatt BF. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell. 2010; 140(1):49-61.","DOI":"10.1016\/j.cell.2009.11.027"},{"key":"41067","doi-asserted-by":"crossref","unstructured":"Snaebjornsson MT, Janaki-Raman S, Schulze A. Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer. Cell Metab. 2020; 31(1):62-76.","DOI":"10.1016\/j.cmet.2019.11.010"},{"key":"41068","doi-asserted-by":"crossref","unstructured":"Schulze A, Harris AL. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature. 2012; 491(7424):364-373.","DOI":"10.1038\/nature11706"},{"key":"41069","doi-asserted-by":"crossref","unstructured":"Han H, Qi R, Zhou JJ. Regulation of the hippo pathway by phosphatidic acid-mediated lipid-protein interaction. Mol Cell. 2018; 72(2):328-340.e8.","DOI":"10.1016\/j.molcel.2018.08.038"},{"key":"41070","doi-asserted-by":"crossref","unstructured":"Martin LJ, Melnichouk O, Huszti E. Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points. J Natl Cancer Inst. 2015; 107(5):djv032.","DOI":"10.1093\/jnci\/djv032"},{"key":"41071","doi-asserted-by":"crossref","unstructured":"Yang MH, Rampal S, Sung J. The association of serum lipids with colorectal adenomas. Am J Gastroenterol. 2013; 108(5):833-841.","DOI":"10.1038\/ajg.2013.64"},{"key":"41072","doi-asserted-by":"crossref","unstructured":"Mulas MF, Abete C, Pulisci D. Cholesterol esters as growth regulators of lymphocytic leukaemia cells. Cell Prolif. 2011; 44(4):360-371.","DOI":"10.1111\/j.1365-2184.2011.00758.x"},{"key":"41073","doi-asserted-by":"crossref","unstructured":"Cicconi L, Fenaux P, Kantarjian H, Tallman M, Sanz MA, Lo-Coco F. Molecular remission as a therapeutic objective in acute promyelocytic leukemia. Leukemia. 2018; 32(8):1671-1678.","DOI":"10.1038\/s41375-018-0219-5"},{"key":"41074","doi-asserted-by":"crossref","unstructured":"de Th\u00e9 H, Chen Z. Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat Rev Cancer. 2010; 10(11):775-783.","DOI":"10.1038\/nrc2943"},{"key":"41075","doi-asserted-by":"crossref","unstructured":"Esnault C, Rahm\u00e9 R, Rice KL. FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias. Blood. 2019; 133(13):1495-1506.","DOI":"10.1182\/blood-2018-07-866095"},{"key":"41076","doi-asserted-by":"crossref","unstructured":"Sohal J, Phan VT, Chan PV. A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657. Blood. 2003; 101(8):3188-3197.","DOI":"10.1182\/blood-2002-06-1800"},{"key":"41077","doi-asserted-by":"crossref","unstructured":"Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature. 2000; 405(6785):421-424.","DOI":"10.1038\/35013000"},{"key":"41078","doi-asserted-by":"crossref","unstructured":"Suchanek KM, May FJ, Robinson JA. Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231. Mol Carcinog. 2002; 34(4):165-171.","DOI":"10.1002\/mc.10061"},{"key":"41079","doi-asserted-by":"crossref","unstructured":"Manieri E, Folgueira C, Rodr\u00edguez ME. JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma. Proc Natl Acad Sci U S A. 2020; 117(28):16492-16499.","DOI":"10.1073\/pnas.2002672117"},{"key":"41080","doi-asserted-by":"crossref","unstructured":"Vickers M, Jackson G, Taylor P. The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation. Leukemia. 2000; 14(4):722-726.","DOI":"10.1038\/sj.leu.2401722"},{"key":"41081","doi-asserted-by":"crossref","unstructured":"Sanz MA, Fenaux P, Tallman MS. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood. 2019; 133(15):1630-1643.","DOI":"10.1182\/blood-2019-01-894980"},{"key":"41082","doi-asserted-by":"crossref","unstructured":"Tallman MS, Nabhan C, Feusner JH, Rowe JM. Acute promyelocytic leukemia: evolving therapeutic strategies. Blood. 2002; 99(3):759-767.","DOI":"10.1182\/blood.V99.3.759"},{"key":"41083","doi-asserted-by":"crossref","unstructured":"Lehmann S, Ravn A, Carlsson L. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia. 2011; 25(7):1128-1134.","DOI":"10.1038\/leu.2011.78"},{"key":"41084","doi-asserted-by":"crossref","unstructured":"Mantha S, Goldman DA, Devlin SM. Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era. Blood. 2017; 129(13):1763-1767.","DOI":"10.1182\/blood-2016-10-747170"},{"key":"41085","doi-asserted-by":"crossref","unstructured":"Cai P, Wu Q, Wang Y, Yang X, Zhang X, Chen S. An effective early death scoring system for predicting early death risk in de novo acute promyelocytic leukemia. Leuk Lymphoma. 2020; 61(8):1989-1995.","DOI":"10.1080\/10428194.2020.1742910"},{"key":"41086","doi-asserted-by":"crossref","unstructured":"Michalik L, Desvergne B, Wahli W. Peroxisome-proliferator-activated receptors and cancers: complex stories. Nat Rev Cancer. 2004; 4(1):61-70.","DOI":"10.1038\/nrc1254"},{"key":"41087","doi-asserted-by":"crossref","unstructured":"Vamecq J, Latruffe N. Medical significance of peroxisome proliferator-activated receptors. Lancet. 1999; 354(9173):141-148.","DOI":"10.1016\/S0140-6736(98)10364-1"},{"key":"41088","doi-asserted-by":"crossref","unstructured":"An integrated encyclopedia of DNA elements in the human genome. Nature. 2012; 489(7414):57-74.","DOI":"10.1038\/nature11247"},{"key":"41089","doi-asserted-by":"crossref","unstructured":"de The H, Pandolfi PP, Chen Z. Acute promyelocytic leukemia: a paradigm for oncoprotein-targeted cure. Cancer Cell. 2017; 32(5):552-560.","DOI":"10.1016\/j.ccell.2017.10.002"},{"key":"41090","doi-asserted-by":"crossref","unstructured":"Tan Y, Wang X, Song H. A PML\/RAR\u03b1 direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia. Blood. 2021; 137(11):1503-1516.","DOI":"10.1182\/blood.2020005698"},{"key":"41091","doi-asserted-by":"crossref","unstructured":"Meshinchi S, Appelbaum FR. Structural and functional alterations of FLT3 in acute myeloid leukemia. Clin Cancer Res. 2009; 15(13):4263-4269.","DOI":"10.1158\/1078-0432.CCR-08-1123"},{"key":"41092","doi-asserted-by":"crossref","unstructured":"Li K, Wang F, Yang Z-N. PML-RAR\u03b1 interaction with TRIB3 impedes PPAR\u03b3\/RXR function and triggers dyslipidemia in acute promyelocytic leukemia. Theranostics. 2020; 10(22):10326-10340.","DOI":"10.7150\/thno.45924"},{"key":"41093","doi-asserted-by":"crossref","unstructured":"Li D, Morris JS, Liu J. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA. 2009; 301(24):2553-2562.","DOI":"10.1001\/jama.2009.886"},{"key":"41094","doi-asserted-by":"crossref","unstructured":"Liu Q, Luo Q, Halim A, Song G. Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer. Cancer Lett. 2017; 401:39-45.","DOI":"10.1016\/j.canlet.2017.05.002"},{"key":"41095","doi-asserted-by":"crossref","unstructured":"Sun J, Lou Y, Zhu J. Hypertriglyceridemia in newly diagnosed acute promyelocytic leukemia. Front Oncol. 2020; 10:577796.","DOI":"10.3389\/fonc.2020.577796"},{"key":"41096","doi-asserted-by":"crossref","unstructured":"Jansen JH, Mahfoudi A, Rambaud S, Lavau C, Wahli W, Dejean A. Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways. Proc Natl Acad Sci U S A. 1995; 92(16):7401-7405.","DOI":"10.1073\/pnas.92.16.7401"},{"key":"41097","doi-asserted-by":"crossref","unstructured":"Grygiel-G\u00f3rniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review. Nutr J. 2014; 13:17.","DOI":"10.1186\/1475-2891-13-17"},{"key":"41098","doi-asserted-by":"crossref","unstructured":"Guerre-Millo M, Gervois P, Rasp\u00e9 E. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem. 2000; 275(22):16638-16642.","DOI":"10.1074\/jbc.275.22.16638"},{"key":"41099","doi-asserted-by":"crossref","unstructured":"Reddy JK, Azarnoff DL, Hignite CE. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature. 1980; 283(5745):397-398.","DOI":"10.1038\/283397a0"},{"key":"41100","doi-asserted-by":"crossref","unstructured":"Girroir EE, Hollingshead HE, He P, Zhu B, Perdew GH, Peters JM. Quantitative expression patterns of peroxisome proliferator-activated receptor-beta\/delta (PPARbeta\/delta) protein in mice. Biochem Biophys Res Commun. 2008; 371(3):456-461.","DOI":"10.1016\/j.bbrc.2008.04.086"},{"key":"41101","doi-asserted-by":"crossref","unstructured":"Ito K, Turcotte R, Cui J. Self-renewal of a purified Tie2+ hematopoietic stem cell population relies on mitochondrial clearance. Science. 2016; 354(6316):1156-1160.","DOI":"10.1126\/science.aaf5530"},{"key":"41102","doi-asserted-by":"crossref","unstructured":"Kelly LM, Kutok JL, Williams IR. PML\/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model. Proc Natl Acad Sci U S A. 2002; 99(12):8283-8288.","DOI":"10.1073\/pnas.122233699"},{"key":"41103","doi-asserted-by":"crossref","unstructured":"Palmqvist L, Argiropoulos B, Pineault N. The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia. Blood. 2006; 108(3):1030-1036.","DOI":"10.1182\/blood-2005-12-007005"},{"key":"41104","doi-asserted-by":"crossref","unstructured":"Reindl C, Quentmeier H, Petropoulos K. CBL exon 8\/9 mutants activate the FLT3 pathway and cluster in core binding factor\/11q deletion acute myeloid leukemia\/myelodysplastic syndrome subtypes. Clin Cancer Res. 2009; 15(7):2238-2247.","DOI":"10.1158\/1078-0432.CCR-08-1325"},{"key":"41105","doi-asserted-by":"crossref","unstructured":"Arsura M, Luchetti M, Erba E, Golay J, Rambaldi A, Introna M. Dissociation between p93B-myb and p75c-myb expression during the proliferation and differentiation of human myeloid cell lines. Blood. 1994; 83(7):1778-1790.","DOI":"10.1182\/blood.V83.7.1778.bloodjournal8371778"},{"key":"41106","doi-asserted-by":"crossref","unstructured":"Naumovski L, Cleary ML. Bcl2 Inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia Cells. Blood. 1994; 83(8):2261-2267.","DOI":"10.1182\/blood.V83.8.2261.bloodjournal8382261"},{"key":"41107","doi-asserted-by":"crossref","unstructured":"Chen L, Zhu HM, Li Y. Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial). Proc Natl Acad Sci U S A. 2021; 118(6)","DOI":"10.1073\/pnas.2020382118"},{"key":"41108","doi-asserted-by":"crossref","unstructured":"Jillella AP, Kota VK. The global problem of early deaths in acute promyelocytic leukemia: a strategy to decrease induction mortality in the most curable leukemia. Blood Rev. 2018; 32(2):89-95.","DOI":"10.1016\/j.blre.2017.09.001"},{"key":"41109","doi-asserted-by":"crossref","unstructured":"Burnett AK, Russell NH, Hills RK. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2015; 16(13):1295-1305.","DOI":"10.1016\/S1470-2045(15)00193-X"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.280147\/74459","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2021.280147\/74965","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10640\/74459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:01:41Z","timestamp":1794045701000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2021.280147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,10,31]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2021.280147","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,12]]}}}